Dapagliflozin Benefits Patients With Type 2 Diabetes, Multiple Risk Factors
Dapagliflozin may reduce the risk for hospitalization for heart failure and adverse renal outcomes regardless of baseline characteristics in patients with type 2 diabetes and multiple risk factors.